Search
The global burden of non-communicable diseases (NCDs) continues to grow. Although developing settings face fastest growth in incidence, no country is exempt.
The association between group A streptococcal infection and rheumatic fever (RF) was established in the early 20th century.
With advancing paediatric healthcare, the use of central venous lines has become a fundamental part of management of neonates and children.
Otitis media (OM) starts within weeks of birth in almost all Indigenous infants living in remote areas of the Northern Territory (NT).
Sepsis is the leading killer of children worldwide, but this is not reflected in estimates of global mortality.
This editorial refers to ‘Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart...
Prevalence and antimicrobial resistance of impetigo pathogens in a randomised, controlled trial of impetigo treatment conducted in remote Indigenous communities
ARC is a global network of collaborators committed to reducing the burden of RHD in our lifetime.
The Australian Strep A Vaccine Initiative (ASAVI) is an Australian-led global initiative with the goal of reducing the disease burden caused by Group A Streptococcus (Strep A) infection through effective vaccination.
The key objective of this study is to collect data about patient and clinician preferences about reformulations.